Factor Bioscience is a life-science company that develops nucleic-acid and cell-based research tools and therapeutics.

Join Team Factor:

Learn more about our team »

Learn more about our technologies »


Funakoshi Co. to Distribute Factor's Products in Japan

Funakoshi Co. will market and distribute Factor Bioscience’s RNA-based reprogramming reagents in Japan, including the FactorStem™ Reprogramming Kit.

Download Press Release

Factor Granted Patent for RNA Reprogramming™ Technology

The U.S. Patent and Trademark Office grants Factor Bioscience a patent for "a method for reprogramming a cell to a less differentiated state" using RNA.

Download Press Release

Download Patent

Factor Launches the FactorStem™ Reprogramming Kit

Factor Bioscience launches the fastest reprogramming kit on the market.

Download Press Release

Try the Kit »

Factor Opens New Lab in Cambridge

Factor Bioscience moves into a newly renovated lab near Inman Square.

Download Press Release

Accelerating Alzheimer’s Research

Factor Bioscience is awarded two NIH grants to accelerate Alzheimer’s disease research.

Download Press Release

Read more news »

UMass Boston highlights Factor's patented RNA Reprogramming™ technology.

Sep 3, 2013 - Matt and Chris discuss the potential of Factor's patented RNA Reprogramming™ technology, and the process of founding a life-science company.

Genetic Engineering News highlights Factor's gene-editing technology.

Mar 1, 2013 - GEN describes how Factor's technologies enable gene-editing with unprecedented efficiency.

Our CEO, Matt, talks with MassHighTech about Factor's Alzheimer's projects.

Nov 14, 2012 - Matt discusses how Factor's recent SBIR awards will impact the field of Alzheimer's research.

Press Resources »